{"DataElement":{"publicId":"6479324","version":"1","preferredName":"Merkel Cell Cancer AJCC Edition 8 Pathologic Tumor T Category","preferredDefinition":"Extent of the primary merkel cell carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"MCC_AJC8_PTH_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6479315","version":"1","preferredName":"Merkel Cell Neoplasm Pathologic T Category","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"6477683v1.0:2207099v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6477683","version":"1","preferredName":"Merkel Cell Neoplasm","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12592:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell","conceptCode":"C12592","definition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E3EF07-8EE9-4141-E053-F662850A90EE","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"77F60C7F-6C98-177A-E053-F662850A4411","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6477701","version":"1","preferredName":"Merkel Cell Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6477701v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tis","valueDescription":"Merkel Cell Carcinoma Tis TNM Finding v8","ValueMeaning":{"publicId":"6477703","version":"1","preferredName":"Merkel Cell Carcinoma Tis TNM Finding v8","longName":"6477703","preferredDefinition":"Merkel cell carcinoma with a finding of in situ primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma Tis TNM Finding v8","conceptCode":"C136843","definition":"Merkel cell carcinoma with a finding of in situ primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B655-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B66E-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"T4","valueDescription":"Merkel Cell Carcinoma cT4 TNM Finding v8","ValueMeaning":{"publicId":"6477705","version":"1","preferredName":"Merkel Cell Carcinoma cT4 TNM Finding v8","longName":"6477705","preferredDefinition":"Merkel cell carcinoma with primary tumor invading fascia, muscle, cartilage, or bone. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cT4 TNM Finding v8","conceptCode":"C136847","definition":"Merkel cell carcinoma with primary tumor invading fascia, muscle, cartilage, or bone. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B67B-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B694-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"T3","valueDescription":"Merkel Cell Carcinoma cT3 TNM Finding v8","ValueMeaning":{"publicId":"6477707","version":"1","preferredName":"Merkel Cell Carcinoma cT3 TNM Finding v8","longName":"6477707","preferredDefinition":"Merkel cell carcinoma with maximum clinical tumor diameter more than 5 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cT3 TNM Finding v8","conceptCode":"C136846","definition":"Merkel cell carcinoma with maximum clinical tumor diameter more than 5 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B6A1-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B6BA-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"T2","valueDescription":"Merkel Cell Carcinoma cT2 TNM Finding v8","ValueMeaning":{"publicId":"6477709","version":"1","preferredName":"Merkel Cell Carcinoma cT2 TNM Finding v8","longName":"6477709","preferredDefinition":"Merkel cell carcinoma with maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cT2 TNM Finding v8","conceptCode":"C136845","definition":"Merkel cell carcinoma with maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B6C7-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B6E0-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"T1","valueDescription":"Merkel Cell Carcinoma cT1 TNM Finding v8","ValueMeaning":{"publicId":"6477711","version":"1","preferredName":"Merkel Cell Carcinoma cT1 TNM Finding v8","longName":"6477711","preferredDefinition":"Merkel cell carcinoma with maximum clinical tumor diameter equal to or less than 2 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cT1 TNM Finding v8","conceptCode":"C136844","definition":"Merkel cell carcinoma with maximum clinical tumor diameter equal to or less than 2 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B6ED-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B706-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"T0","valueDescription":"Merkel Cell Carcinoma cT0 TNM Finding v8","ValueMeaning":{"publicId":"6477713","version":"1","preferredName":"Merkel Cell Carcinoma cT0 TNM Finding v8","longName":"6477713","preferredDefinition":"Merkel cell carcinoma with no evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cT0 TNM Finding v8","conceptCode":"C136842","definition":"Merkel cell carcinoma with no evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B713-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B72C-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"TX","valueDescription":"Merkel Cell Carcinoma cTX TNM Finding v8","ValueMeaning":{"publicId":"6477715","version":"1","preferredName":"Merkel Cell Carcinoma cTX TNM Finding v8","longName":"6477715","preferredDefinition":"Merkel cell carcinoma in which the primary tumor cannot be assessed (e.g., curetted). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cTX TNM Finding v8","conceptCode":"C136841","definition":"Merkel cell carcinoma in which the primary tumor cannot be assessed (e.g., curetted). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B739-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E62A8E-B752-3701-E053-F662850AE8EF","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6477700","version":"1","preferredName":"Merkel Cell Carcinoma TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C136832:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma TNM Finding v8","conceptCode":"C136832","definition":"A finding about one or more characteristics of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E62A8E-B628-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77E62A8E-B639-3701-E053-F662850AE8EF","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-10-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6477698","version":"1","longName":"Merkel Cell","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic T category","type":"Preferred Question Text","description":"Pathologic T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F757C0-7DE7-0B64-E053-F662850A8A50","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}